Dimensional Fund Advisors’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPX
Dimensional Fund Advisors's CMPX Position: Q3 2026 in Review
Dimensional Fund Advisors increased its Compass Therapeutics (CMPX) stake by 58% in Q3 2026, buying an estimated $648K and bringing the position to 855,724 shares worth $891K. The position accounts for ﹤0.01% of the portfolio, ranked #2852.
Dimensional Fund Advisors first reported a position in CMPX in Q2 2023 and has held it in 14 quarters since. The position peaked at $2.32M in Q1 2026. 33 funds tracked by Wall St. Rank hold CMPX as of Q3 2026.
- Dimensional Fund Advisors held 855,724 shares of Compass Therapeutics worth $891K as of Q3 2026.
- Dimensional Fund Advisors bought 314,546 Compass Therapeutics shares in Q3 2026, an estimated $648K.
- Compass Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2026, its #2852 holding.
- Dimensional Fund Advisors first reported a position in Compass Therapeutics in Q2 2023 and has held it in 14 quarters since.
- Dimensional Fund Advisors's Compass Therapeutics position peaked at $2.32M in Q1 2026.
- 33 funds tracked by Wall St. Rank held Compass Therapeutics as of Q3 2026.
Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.